About this Medicine article
Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism by Valle Raleigh, Juan (author);Mauro, Adolfo G. (author);Devarakonda, Teja (author);Marchetti, Carlo (author);He, Jun (author);Kim, Erica (author);Filippone, Scott (author);Das, Anindita (author);Toldo, Stefano (author);Abbate, Antonio (author);Salloum, Fadi N. (author) is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Valle Raleigh, Juan (author);Mauro, Adolfo G. (author);Devarakonda, Teja (author);Marchetti, Carlo (author);He, Jun (author);Kim, Erica (author);Filippone, Scott (author);Das, Anindita (author);Toldo, Stefano (author);Abbate, Antonio (author);Salloum, Fadi N. (author)
- Publisher
- Oxford University Press
- Published
- 2017
- Language
- EN
- Field
- Medicine (Health Sciences)